Key words: asthma; airway hyperresponsiveness; dupilumab; IL-4
receptor α chain
FUNDING INFORMATION
This work was supported in part by a grant from the National Research
Institute for Child Health and Development of Japan (2020B-4 to KM).
CONFLICT OF INTEREST
The authors declare that they have no relevant conflicts of interest.
AUTHOR CONTRIBUTIONS
Kuzume, Kazuyo (Corresponding Author) Conceptualization
(Equal) Data curation (Equal)Formal analysis (Equal) Investigation
(Equal) Project administration (Equal)
Resources (Equal) Software (Equal) Supervision (Equal)Validation
(Equal)
Visualization (Equal) Writing-original draft (Equal) Writing-review &
editing (Equal)
Kuwabara, Yu Conceptualization (Equal) Data curation (Equal)
Writing-review & editing (Equal) Tokuda, Kiriko Data curation
(Equal) Supervision (Equal)
Writing-review & editing (Equal) Matsumoto, KenjiConceptualization (Equal)
Formal analysis (Equal) Funding acquisition (Equal) Project
administration (Equal)
Resources (Equal) Supervision (Equal) Validation (Equal) Visualization
(Equal) Writing-original draft (Equal) Writing-review & editing (Equal)
Kazuyo Kuzume, MD, PhD1,2
Yu Kuwabara, MD, PhD1,2
Kiriko Tokuda, MD, PhD1,2
Kenji Matsumoto, MD, PhD3
1 Department of Pediatrics, Ehime University School of
Medicine, Ehime, Japan2 Department of Pediatrics, Yawatahama City General
Hospital, Ehime, Japan3 Department of Allergy and Clinical Immunology,
National Research Institute for Child Health and Development,
Tokyo, JapanCorrespondenceKazuyo Kuzume, Department of Pediatrics, Ehime University School of
Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.
Phone: +81-89-960-5320, Fax: +81-89-960-5941,
E-mail: kuzumekazuyo@ybb.ne.jp
Kenji Matsumoto, Department of Allergy and Clinical Immunology,
National Research Institute for Child Health and Development,
2-10-1, Okura, Setagaya-ku, Tokyo 157-8535, Japan
Phone: +81-3-5494-7120 (ext. 4950); FAX: +81-3-5494-7173;
E-mail: matsumoto-k@ncchd.go.jp